A pharmaceutical company sued several prominent telehealth companies for what they call "illegal knock offs" of their drugs.

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Operator: Greetings and welcome to the BiomX First Quarter 2025 Financial Results Conference Call. At this time, all ...